Integrated Treatment of the Adult Geriatric Male Patient
|
|
- Maryann Carroll
- 5 years ago
- Views:
Transcription
1 Michigan Osteopathic Association David D. Wartinger, D.O., J.D. Michigan State University College of Osteopathic Medicine May 13, Integrated Treatment of the Adult Geriatric Male Patient BPH Prostate Cancer Low Testosterone Erectile Dysfunction Incontinence Hematuria 1
2 The Urological Magic Bullet 5 alpha Reductase Inhibitor Proscar/Avodart Alpha Adrenergic Blocker Minipress / Hytrin / Cardura / Flowmax / Uroxatrol / Rapiflo Testosterone Replacement Androderm / Androgel / Testim/ Axiron/ Fortesta/ Natesto / Striant / injection or implant / not Oral Erectile Dysfunction Viagra/ Levitra / Cialis 1 st choice for symptomatic BPH, low T and ED Avodart 0.5 mg PO q daily Uroxatrol 10 mg PO q daily AndroGel 2 pumps q AM applied to skin Cialis 5 mg PO q bedtime 2
3 Transitional Zone develops BPH Peripheral Zone develops CaP 5 Obstructive Voiding Symptoms Decreased force of stream Hesitancy Straining Incomplete bladder emptying Nocturia 6 3
4 Irritative Voiding Symptoms Frequency Urgency Occasionally dysuria 7 Voiding Dysfunction Factors Changes in bladder, prostate and /or urethra Bladder instability Decreased bladder compliance Urethral stricture; bladder neck contracture 8 4
5 BPH Natural History Incidence of AUR or Significance PVR 2% per year 9 Figure 2. The validated AUA Symptom Score tool for voiding symptoms 10 5
6 Medical Therapy for BPH Shrink or stop growth of prostate Open urethral channel within prostate 11 Inhibit Production of DHT finasteride (Proscar) 1992 dutasteride (Avodart) 2001 Prevent or reduce acinar gland growth 12 6
7 Relax Smooth Muscle of Prostate and Bladder Neck Alpha Blockers Antihypertensives terazosin (Hytrin) doxazosin (Cardura) Prostate Specific tamsulosin (Flomax) alfuzosin (Uroxatrol) 13 Minimally Invasive Procedures for BPH Transurethral microwave procedures (TUMT) Transurethral needle ablation (TUNA) Water-induced thermotherapy High intensity focused ultrasound (HIFU) 14 7
8 Conventional Surgical Therapy Transurethral Resection of the Prostate Gold Standard treatment Resectoscope minute operation Wire loop General or spinal anesthesia 15 Laser Surgery Variations for BPH Photo selective Vaporization of the Prostate (PVP) Interstitial Laser Coagulation (ILC) 16 8
9 Prostate Cancer: Screening and Management Prostate Cancer (CaP) Treatment Stratagem Early detection while tumor confined to prostate or surrounding tissues and can be cured by either removal or treatments aimed at the primary 17 Prostate Cancer: Screening and Management PSA and Overdiagnosis Identification of patients with CaP that don t benefit from diagnosis or treatment of their disease 18 9
10 Prostate Cancer: Screening and Management United States Preventative Services Task Force (USPSTF) Fair evidence that [PSA Screening] is ineffective or that harms outweigh the benefits. PSA screening and DRE in asymptomatic patients 19 Prostate Cancer: Screening and Management AUA DISAGREES with USPSTF PSA used since 1986, total CaP deaths decreased 30% Decreased dire consequences of advanced CaP American Cancer Society (ACS) and the American Society of Clinical Oncologists (ASCO) agree with AUA 20 10
11 Prostate Cancer: Screening and Management Localized Prostate Cancer Treatment Radiation Surgery Cryosurgery High intensity focused ultrasound Expectant management (watchful waiting) 21 Prostate Cancer: Screening and Management Hormone Therapy for CaP Most commonly used after metastasis Only palliative, not curative Hormone refractory or androgen independent 22 11
12 Prostate Cancer: Screening and Management Summary of CaP Treatment No free lunch Surgery with 30 year life expectancy, localized CaP Radiation or expectant management for patients, over 70 years of age and localized CaP Metastatic CaP, palliative with hormone manipulation 23 Testosterone Replacement 1. Only men with symptoms of low testosterone 2. Blood levels confirm low testosterone as cause of symptoms 12
13 Symptoms of Low Testosterone Low sex drive (libido) Erectile dysfunction Fatigue and poor energy level Decreased muscle mass Hair loss Difficulty concentrating Depression Irritability Low sense of well-being Forms of Testosterone Skin patch (transdermal): Androderm worn on arm or upper body, applied once a day Gels: AndroGel and Testim absorbed through skin, applied once a day, comes in packets AndroGel, Axiron and Fortesta comes in pump Natesto gel applied inside the nose Mouth Patch: Striant tablet sticks to upper gums, applied twice a day Injections and implants: Injection directly into the muscles Implanted pellets into the soft tissue Oral? Negative effects on liver Bypass the liver with other delivery methods 13
14 Risks of Testosterone Therapy Rash, itching or irritation at application site Evidence for increased risk of: Heart attack Stroke Acne Fluid Retention Breast Enlargement Decreased Testes Size Increased Aggression Mood Swings Decreased Sperm Count Infertility PSA Increase Cholesterol/Lipids Benefits and Risks of long-term testosterone therapy are UNKNOWN. 14
15 Conditions that may worsen with testosterone therapy Benign Prostatic Hypertrophy (BPH): Prostate grows naturally under the stimulation of testosterone Prostate Cancer (CaP): Can stimulate prostate cancer to grow Screen for CaP before starting testosterone CaP or elevated PSA should probably not receive testosterone treatment Sleep Apnea Blood Clots: Risk of deep vein thrombosis and pulmonary embolism Congestive Heart Failure Testosterone Replacement vs. Performance Enhancing Steroids Testosterone replacement only achieves physiologic levels of hormone Doping uses much higher doses of testosterone and often combined ( stacked ) with other substances 15
16 Definition The inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse 31 Erectile Dysfunction Estimated to affect million men in the US One or more factors Psychological Neurologic Hormonal Arterial Venous 32 16
17 Erectile Dysfunction Silent Marker for later development of cardiovascular disease 33 Figure 1. Anatomy of the Penis. The penile erection occurs as a result of 3 processes: a) smooth muscle relaxation among arteries and trabecular tissue increases blood flow, which b) lengthens and enlarges penis through sinusoidal filling, and c) expanded sinusoids compress the subtunical venous plexus, reducing venous outflow
18 Block Phosphodiesterase Enzyme Activity Sildenafil Vardenafil Tadalafil 35 Hormonal ED Androgen deficiency Decrease in nocturnal erections decreases libido Erections with visual sexual stimulation preserved Androgen may not be essential for erection 36 18
19 Sexual Function over time Progressively declines in healthy aging men Latent period between sexual stimulation and erections increases Erections are less turgid Ejaculation less forceful Ejaculatory volume decreases Refractory period between erections lengthens Decrease in serum testosterone 37 Recommended Laboratory Tests Urinalysis Complete Blood Count Fasting blood glucose Creatinine Cholesterol Triglycerides Testosterone 38 19
20 If Testosterone low Serum free (or bioavailable) testosterone Prolactin Lutenizing hormone 39 Erectile dysfunction is not just a sexual health issue, it may be a serious harbinger of lifethreatening cardiovascular conditions 40 20
21 ED is as important a CV disease risk factor as Smoking, or Family history of Heart Disease 41 Erectile Dysfunction Treatment Drug Therapy Administration: oral, injected directly into penis, inserted into distal urethra March 1998 sildenafil, first pill Vardenafil and tadalafil Phosphodiesterse (PDE) inhibitors 42 21
22 Erectile Dysfunction Treatment Intracavernosal Injections Inject drugs into penis to engorge with blood Papaverine hydrochloride, phentolamine, and alprostadil (a prostaglandin E2) Widen blood vessels, induce and maintain erections Side effects: persistent erection (priapism) and scarring 43 Erectile Dysfunction Treatment Intraurethral Injections Insert pellet of alprostadil into urethra, prefilled applicator MUSE, inch into urethra Onset 8 to 10 minutes, may last 30 to 60 minutes Side effect: penile pain, warmth or burning sensation in urethra, redness of penis, minor urethra bleeding or spotting 44 22
23 Erectile Dysfunction Treatment Vacuum Erection Devices Creates partial mechanical vacuum Draws blood into penis, engorging and expanding it 3 components: plastic cylinder, pump and elastic band 45 Erectile Dysfunction Treatment Penile Surgery Procedures to improve erections 1. Implant a device, make rigid 2. Reconstruct arteries, improve flow 3. Occlude veins, prevent leak 46 23
24 Often treatable Identify patients who might benefit from treatment Treatment depends on etiology Identify the etiology Urge Incontinence Sudden sensation to void Unable to suppress sensation fully Severe case, may not be aware sensation until actually leaking 24
25 Overactive Bladder (OAB) Newer term Frequency and Urgency With or without Urge Incontinence Overflow Incontinence Occurs at extreme bladder volumes, or Bladder volume reaches the limit of viscoelastic properties Elevation in detrusor pressure Incomplete bladder emptying Obstruction Poor bladder contractility 25
26 Overflow Incontinence Symptoms Constant dribbling Extreme frequency Evaluation of the Incontinent Patient History Physical examination Laboratory tests Possibly urodynamic testing 26
27 Evaluation of the Incontinent Patient Urinalysis Hematuria Pyuria Glucosuria Proteinura Cytology, if hematuria or irritative voiding symptoms Evaluation of the Incontinent Patient Urine Culture and Sensitivity if Pyuria Bacteriuria Treat infection prior to further W/U > 3 RBC/HPF, further investigation 27
28 Evaluation of the Incontinent Patient Post Void Residual (PVR) Measure with ultrasound or catheter Normal <50ml / >200 ml abnormal Increased PVR, Bladder outlet obstruction Poor bladder contractility Differentiate with urodynamic testing Treatment of Urge Incontinence Bladder contracts with or without warning Timed voiding Remind patients to void every 1-2 hours during the day Void before urge to void 28
29 Urge Incontinence Anticholinergic Antimuscarinics Mainstay of medical therapy Side Effects Urinary retention Dry mouth Constipation Nausea Blurred vision Tachycardia Drowsiness Confusion Urge Incontinence Poor Bladder Compliance Primary Goal: treat high bladder pressure Complete bladder emptying ICC and anticholinergics May add to anticholinergic antimuscarinics and alpha-agonists Bladder augmentation when medical management fails 29
30 Treatment of Overflow Incontinence Treated by emptying the bladder Relieve Obstruction Males Urethral stricture Prostatic obstruction Treatment of Urethral Stricture Disease Urethral dilation Internal urethrotomy Urethroplasty 30
31 Treatment of Prostatic Obstruction Gold Standard TURP Transurethral Resection of the Prostate Treatment of Overflow Incontinence Poor detrusor contractility ICC (intermittent clean catheterization) 31
32 Treatment of Indwelling Catheters Not optimum long term treatment Eventually infected urine Predisposes to bladder calculi Possible ultimate squamous cell carcinoma Treatment of Males with Stress Incontinence Artificial urinary sphincter Cuff compresses bulbar urethra Gold Standard Male slings Compress under urethra Elevate the urethra to more retro pubic position Lesser degrees of incontinence, pad weight test 32
33 Summary Key Diagnostic Points Urge Incontinence Symptoms Urgency Frequency Nocturia Unable to reach the toilet with urge Summary Key Diagnostic Points Stress Incontinence Symptoms Leakage with physical activity Signs Bladder neck mobility Positive stress test 33
34 Summary Key Diagnostic Points Mixed Incontinence Symptoms Urgency Frequency Nocturia Unable to reach the toilet with urge Leakage with physical activity Signs Bladder neck mobility Positive stress test Summary Key Diagnostic Points Overflow Incontinence Symptoms Frequency Nocturia Urgency Leakage with physical activity Signs High post void residual 34
35 Summary Key Treatment Urge Incontinence Avoidance of bladder irritants Timed voiding Pelvic muscle exercises Weight loss Summary Key Treatment Urge Incontinence Anticholinergics Antimuscarinics - Nonselective for M3 Receptor Propantheline (Pro-Banthine) 7.5 to 30 mg orally, three to five times daily Tolterodine (Detrol LA) 4 mg orally daily Trospium (Sanctura) 20 mg orally two times daily Solifenacin (Vesicare) 5 10 mg orally, daily 35
36 Summary Key Treatment Urge Incontinence Anticholinergics Antimuscarinics Selective for M3 Receptor Darifenacin (Enablex) 7.5 to 15 mg orally, daily Summary Key Treatment Urge Incontinence Anticholinergic Antimuscarinics/Smooth Muscle Relaxant Oxybutynin Regular (Ditropan) 2.5 to 5.0 mg orally, one to three times daily Extended Release (Ditropan XL) 5 30 mg orally, daily Transdermal (Oxytrol) 4.9 mg patch twice per week Hyoscyamine (Lesin) to mg orally, two to four times daily 36
37 Summary Key Treatment Urge Incontinence Anticholinergic/Alpha-Agonist For urge or mixed Imipramine (Tofranil) Not FDA approved for this indication 10 to 25 mg, once to three times daily Summary Key Treatment Stress Incontinence Behavioral Changes Weight loss Quitting smoking Pelvic muscle exercises 37
38 Summary Key Treatment Stress Incontinence Alpha Agonists Pseudoephedrine (Sudafed) Not FDA approved for this indication 30 to 60 mg, up to four times per day Summary Key Treatment Stress Incontinence Anitcholinergics / Alpha Agonist Imipramine (Tofranil) Not FDA approved for this indication 10 to 25 mg, once to three times daily 38
39 HEMATURIA REFERENCE CHART MICHIGAN STATE UNIVERSITY ml ml ml ml ml ml ml ml ml ml ml ml SG U Row A SG U Row B SG U Row C Column = Added ML Blood Per Cup Specimen Cup 50 ML Rows = Specific Gravity of Urine SG U VISUAL ESTIMATION OF BLOOD IN GROSS HEMATURIA IRB #02-970/APP #i David D. Wartinger, D.O., J.D. Osteopathic Surgical Specialties College of Osteopathic Medicine Michigan State University Shannon Grochulski-Fries ABSTRACT Very small amounts of blood can be visually detected in the urine and may be the only warning sign of a life threatening problem. A systematic documentation of the visual appearance of gross hematuria specimens was not previously performed. The clinical advantage of possessing a library of photographs documenting exact volumes of blood in known urine specimen volumes was not appreciated. To simulate hematuria, known quantities of anticoagulated blood were added to 50 ml urine specimens of various specific gravities/concentrations and then photographed on white graph paper. The gross hematuria specimen photographs were arranged sequentially to create a Hematuria Reference Chart. An unknown hematuria specimen can now be visually matched to the Hematuria Reference Chart to determine blood loss per ml of voided urine. The Hematuria Reference Chart is available on-line to health care INTRODUCTION professionals and patients for documentation, education and diagnosis. Hematuria is not normal and its cause must be determined. Most episodes of gross hematuria are not due to life threatening conditions or diseases; but, some OBJECTIVE: episodes are the only warning sign of a life threatening problem. Very small amounts of blood can be visually detected in urine and the amount of blood does not reliably predict the seriousness of the underlying cause of the hematuria. The presence of visible blood in the urine can cause fear and anxiety in patients and healthcare providers alike. Accurately estimating the volume of blood mixed in the urine can help direct treatment and eliminate unwarranted concerns of serious blood loss. Without a reference standard, estimating blood loss from hematuria is imprecise and without scientific basis. CAUSES OF HEMATURIA Cancer Trauma Inflammation Infection Foreign Bodies Vascular Glomerular Disease Hematologic Activity Menstruation Loin Pain Hematuria Syndrome METHODS AND MATERIALS A photographic library of simulated gross hematuria specimens was created and arraigned to produce a hematuria reference chart. Voided urine was collected from a solitary volunteer during various hydration states to obtain urine of different specific gravities / concentration. Increasing amounts of whole anti-coagulated blood were added to volumes of collected urine to create 50 ml simulated gross hematuria specimens. The simulated gross hematuria specimens were photographed (in clear urine specimen cups) on white graph paper background with blue lines. All of the simulated gross hematuria specimen photographs and the Hematuria Reference Chart were uploaded to YouTube and Google Images. PROCEDURE FOR USING HRC Example: Step 1: Verify a total of 50 ml of gross hematuria sample in a clear standard 120 ml urine specimen cup viewed on a background of white graph paper. Step 2: Select the most appropriate row based on urine specific gravity and match the unknown specimen to the column of added blood on the HRC. Step 3: Calculate blood loss from hematuria (Voided volume/50 X added blood volume from HRC/cup) = total whole blood loss in ml/void. If patient voids 500 ml: 500ml/50=10; 10 x 0.034ml= 0.34 total whole blood loss ml/void DISCUSSION The online availability of the Michigan State University College of Osteopathic Medicine Hematuria Reference Chart enables patients and health care providers to quantify and document hematuria. Even when patients don t have online access to the Hematuria Reference Chart, they can photograph their hematuria specimen using a smartphone and send the pictures to their caregiver for comment. Urinary blood loss can now be tracked over the duration of the disease. The Hematuria Reference Chart is both an educational and diagnostic tool with documentation capabilities. This study was approved by the Michigan State University IRB: IRB#: SI 39
Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine
Victoria Sharp, MD, MBA, FAAFP Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Market Chief Medial Officer AmeriHealth Caritas Family of Companies Office phone: (515) 330-3740
More informationMODULE 3: BENIGN PROSTATIC HYPERTROPHY
MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student
More informationWhat is Benign Prostatic Hyperplasia (BPH)?
What is Benign Prostatic Hyperplasia (BPH)? Benign prostatic hyperplasia (BPH) is an enlarged prostate. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty,
More informationManagement of LUTS after TURP and MIT
Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent
More informationBenign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome
More informationMANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH
MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size
More informationBenign Prostatic Hyperplasia (BPH):
Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate
More informationVoiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.
Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.
More informationPatient Expectations Following Greenlight XPS
Patient Expectations Following Greenlight XPS 1. Hematuria it is common for men to have light pink to cherry red urine following the procedure. This small amount of blood in the urine usually resolves
More informationProstate Disease. Chad Baxter, MD
Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of
More informationThe Enlarged Prostate Symptoms, Diagnosis and Treatment
The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with
More informationMen s Health Topics. Learning Objectives. BPH Definition. The Prostate Gland. I have nothing to disclose. Mindi Miller, Pharm. D.
I have nothing to disclose Men s Health 2016 Mindi Miller, Pharm. D., BCPS Topics Benign Prostatic Hyperplasia Erectile Dysfunction Learning Objectives Describe common lower urinary tract symptoms (LUTS)
More informationProstate surgery. What is the prostate? What is a TURP? Why is a TURP operation necessary? Deciding to have a TURP operation.
What is the prostate? The prostate is a gland about the size of a walnut that is only present in men. It is located just below the bladder and surrounds the urethra, the tube through which urine flows
More informationPROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment
PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.
More informationProstate Enlargement: Benign Prostatic Hyperplasia
Prostate Enlargement: Benign Prostatic Hyperplasia National Kidney and Urologic Diseases Information Clearinghouse What is benign prostatic hyperplasia? Benign prostatic hyperplasiaalso called BPHis a
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationMODULE 9: URINARY INCONTINENCE
MODULE 9: URINARY INCONTINENCE KEYWORDS: PROSTATIC HYPERTROPHY, PROSTATIC HYPERPLASIA, PSA, VOIDING DYSFUNCTION, LOWER URINARY TRACT SYMPTOMS (LUTS). Learning Objectives At the end of this clerkship, the
More informationBladder Dysfunction in Multiple Sclerosis. by Nancy J. Holland, EdD, RN and Nancy C. Reitman, MA, RN
Clinical Bulletin Information for Health Professionals Bladder Dysfunction in Multiple Sclerosis by Nancy J. Holland, EdD, RN and Nancy C. Reitman, MA, RN Effective bladder management strategies make it
More informationBenign Prostatic Hyperplasia. Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy
Benign Prostatic Hyperplasia Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy Definition BPH is a common disorder that increases in frequency
More informationOverview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
More informationTrans Urethral Resection of Prostate (TURP)
Trans Urethral Resection of Prostate (TURP) Patient Information Author ID: SF Leaflet Number: Urol 010 Version: 6 Name of Leaflet: Trans Urethral Resection of Prostate (TURP) Date Produced: March 2018
More information10/9/2015. Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University
Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University 1. Explain the pathophysiology of benign prostatic hyperplasia (BPH),
More informationUrinary Incontinence for the Primary Care Provider
Urinary Incontinence for the Primary Care Provider Diana J Scott FNP-BC https://youtu.be/gmzaue1ojn4 1 Assessment of Urinary Incontinence Urge Stress Mixed Other overflow, postural, continuous, insensible,
More informationUrinary tract disorders
Urinary tract disorders Medicines Formulary Contents: 1. Urinary retention 1 2. Urinary incontinence 2 3. Urethral pain prevention during catheterisation 3 4. Indwelling catheters maintenance of patency
More informationLower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital
Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of
More informationBenign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy
Benign Prostatic Hyperplasia Management of Benign Prostatic Hyperplasia Goals of Therapy Improve or abolish lower urinary tract symptoms (LUTS) Prevent or delay clinical progression of benign prostatic
More informationURINARY INCONTINENCE
Center for Continence Care and Pelvic Medicine What is urinary incontinence? URINARY INCONTINENCE Urinary incontinence is the uncontrollable loss of urine. The amount of urine leaked can vary from only
More informationP ROLIEVE. Thermodilatation System. The Prolieve System Patient Information is Directed to You, the Patient. A Transurethral Microwave Therapy Device
P ROLIEVE Thermodilatation System A Transurethral Microwave Therapy Device The Prolieve System Patient Information is Directed to You, the Patient. Contents Why am I being treated with the Prolieve Thermodilatation
More informationBenign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary
Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,
More information김준철 가톨릭대학교의과대학비뇨기과학교실
비뇨기계자율신경병증의치료 김준철 가톨릭대학교의과대학비뇨기과학교실 Introduction Urologic complications have increasingly become a concern in those affected by DM Genitourinary problems are included among these complications, related
More informationProstate Health PHARMACIST VIEW
Prostate Health PHARMACIST VIEW Prostate Definition Prostate is a gland made of fibromuscular tissue. It is about 4 cm and surrounds the neck of the bladder and the urethra. It produces seminal fluid.
More informationAll about the Prostate
MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,
More informationOveractive Bladder. When to see a doctor. Normal bladder function
Overactive Bladder Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary
More informationManagement of LUTS. Simon Woodhams February 2012
Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract
More informationAppendix 2 Drug Information
Appendix 2 Drug Information Chemical Name: baclofen (bak-loe-fen) Brand Name: Lioresal (U.S. and Canada) Description: Baclofen acts on the central nervous system to relieve spasms, cramping, and tightness
More informationMale Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon
Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS
More informationDr. Aso Urinary Symptoms
Haematuria The presence of blood in the urine (haematuria) is always abnormal and may be the only indication of pathology in the urinary tract. False positive stick tests and the discolored urine caused
More informationManaging Symptoms after Prostate Cancer Sexual Side Effects for Gay and Bisexual Men Changes in a man s sex life are common and can be managed.
Managing Symptoms after Prostate Cancer Sexual Side Effects for Gay and Bisexual Men Changes in a man s sex life are common and can be managed. Even without prostate cancer, getting older can cause changes
More informationManaging Symptoms after Prostate Cancer Sexual Side Effects. Changes in a man s sex life are common and can be managed.
Managing Symptoms after Prostate Cancer Sexual Side Effects Changes in a man s sex life are common and can be managed. Prostate cancer and its treatment often bring changes in a man s sex life, especially
More informationRezūm procedure for the Prostate
Rezūm procedure for the Prostate Mr Jas Kalsi Consultant Urological Surgeon This booklet has been provided to help answer the questions you may have with regards to your enlarged prostate and the Rezūm
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More information50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?
PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS What is Benign Prostatic Hyperplasia (enlarged prostate)? Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate, the gland that
More informationOveractive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based
Overactive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based upon a medical history, and includes a focused physical exam (abdominal, neurological, pelvic in females and
More informationLoss of Bladder Control
BLADDER HEALTH: Surgery for Urinary Incontinence Loss of Bladder Control Surgery for Urinary Incontinence Don t Let Urinary Incontinence Keep You from Enjoying Life. What is Urinary Incontinence? What
More informationObjectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS
URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS Lisa S Pair, MSN, CRNP Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology University of Alabama
More informationDiagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. TARGET POPULATION Eligibility Decidable (Y or N) Inclusion Criterion non-neurogenic OAB Exclusion Criterion
More informationCanadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases
Canadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases LUTS/Benign Prostate Hyperplasia Objectives 1. List the lower urinary tract symptoms (LUTS) found in men with BPH. 2. List the differential
More informationCialis. Cialis (tadalafil) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)
More informationErectile Dysfunction
Erectile Dysfunction WWW.RN.ORG Reviewed May, 2017, Expires May, 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017 RN.ORG, S.A., RN.ORG, LLC Erectile
More informationPolicy for Prostatism/Lower Urinary Tract Symptoms in men
NHS Halton Clinical Commissioning Group NHS Liverpool Clinical Commissioning Group NHS St Helens Clinical Commissioning Group NHS South Sefton Clinical Commissioning Group NHS Southport and Formby Clinical
More informationNOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate
NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December
More informationSome people experience occasional, minor leaks of urine. Others wet their clothes frequently.
Urinary Incontinence Urinary incontinence the loss of bladder control is a common and often embarrassing problem. The severity ranges from occasionally leaking urine when you cough or sneeze to having
More informationURINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Definition The involuntary loss of urine May denote a symptom, a sign or a condition Symptom the
More informationDisclosures. Geriatric Incontinence and Voiding Dysfunction. Agenda. Agenda. UI: a Geriatric Syndrome. Geriatric Syndromes 9/7/2018.
Disclosures Geriatric Incontinence and Voiding Dysfunction None Shachi Tyagi MD, MS Assistant Professor Division of Geriatric Medicine University of Pittsburgh Medical Center UI: a Geriatric Syndrome Geriatric
More information, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001
Erectile Dysfunction David Stultz, MD September 10, 2001 Case Presentation A 66 year old male presents to your office requesting Viagra. He states that for the past year he has had difficulty forming
More informationErectile Dysfunction National Kidney and Urologic Diseases Information Clearinghouse
Erectile Dysfunction National Kidney and Urologic Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH U.S. Department of Health
More informationBenign Prostatic Hyperplasia (BPH) IPT VI Srikanth Kolluru, Ph.D
Benign Prostatic yperplasia (BP) IPT VI Srikanth Kolluru, Ph.D. kolluru@tamhsc.edu, 361 221 0741 verview 1. Introduction and background of BP 2. Causes and common symptoms 3. Treatment options Learning
More informationClinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97
Lower urinary tract symptoms in men: management Clinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationManagement of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction
Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction Robert C. Eyre, MD, FACS Associate Clinical Professor of Surgery (Urology) Harvard Medical School Post-prostatectomy Incontinence
More informationUrinary Adverse Events after Radiation Therapy for Prostate Cancer
Urinary Adverse Events after Radiation Therapy for Prostate Cancer Sexual Medicine Society of North America Scottsdale, Arizona 2016 Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial Sloan
More informationDefinition of Andropause
HORMONE REPLACEMENT THERAPY FOR MEN Thomas C. Reed R.Ph., F.A.C.A. Reed s Compounding Pharmacy 2729 E. Speedway 318-4421 reedsrx.com 7/7/2010 1 Definition of Andropause A gradual decline in sex hormone
More informationManaging the Patient with Erectile Dysfunction: What Would You Do?
Managing the Patient with Erectile Dysfunction: What Would You Do? Florida A & M University College of Pharmacy and Pharmaceutical Sciences 42 nd Annual Clinical Symposium Wayne A. Sampson, M.D. Cross
More informationTHE OVER-ACTIVE BLADDER (OAB)
THE OVER-ACTIVE BLADDER (OAB) Passage of urine is caused by the bladder muscle contracting coordinated with the relaxation of the sphincter muscles, which is controlled by higher centers in the central
More informationCialis. Cialis (tadalafil) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
More informationCanadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction
Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction Last reviewed July 2014 Objectives 1. Define erectile dysfunction 2. List and classify the risk factors for erectile dysfunction
More informationIncontinence: Risks, Causes and Care
Welcome To Incontinence: Risks, Causes and Care Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa September 5, 2018 10:00 11:00
More informationOveractive bladder. Information for patients from Urogynaecology
Overactive bladder Information for patients from Urogynaecology An overactive bladder (OAB) is a very common problem. It can cause distressing symptoms that are difficult to control. These can include
More informationSexual Function for Men with Spinal Cord Injury
Sexual Function for Men with Spinal Cord Injury A spinal cord injury (SCI) affects a man's sexuality both physically and psychologically. The type and level of injury both can play a role on the impact
More informationBenign prostatic hyperplasia (BPH)
Diseases and Conditions Benign prostatic hyperplasia (BPH) By Mayo Clinic Staff Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate
More informationPharmacology: Genitourinary. Lecturer: JACOBS
Pharmacology: Genitourinary Lecturer: JACOBS 1 Conditions Covered In This Lecture: Benign prostatic hyperplasia (BPH) Erectile dysfunction Urinary Incontinence 2 Prostate Pharmacology: Genitourinary Fibrous,
More informationAdvanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa
Advanced Care for Female Overactive Bladder & Urinary Incontinence Department of Urology Kaiser Permanente Santa Rosa Goals Participants will: Review normal urinary tract anatomy and function Understand
More informationManagement of male LUTS in general practice
17 Management of male LUTS in general practice MARK J. SPEAKMAN AND FAITH MCMEEKIN The initial management of lower urinary tract symptoms in men is usually carried out in primary care. The authors explain
More informationR. Matthew Smith M.D. Stacy Pohlman, ARNP Jessica Gengler, PT, DPT Mercy Urology
R. Matthew Smith M.D. Stacy Pohlman, ARNP Jessica Gengler, PT, DPT Mercy Urology Disclosures Matt Smith None Stacy Pohlman None Jessica Gengler None Topics Clinical Pathway Development Prostate Cancer
More informationGeriatric Urinary Incontinence
Geriatric Urinary Incontinence Neil M. Resnick, MD Thomas Detre Professor of Medicine Chief, Division of Geriatric Medicine University of Pittsburgh/UPMC UI: The Problem Prevalence in elderly 33% Morbidity
More informationPROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA
St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO
More informationEvaluation and Treatment of Incontinence
Evaluation and Treatment of Incontinence Classification of Incontinence Failure to empty: Overflow incontinence Failure to store Stress Incontinence Urge Incontinence Physiology of voiding CNS Brain sends
More informationThe Neurogenic Bladder
The Neurogenic Bladder Outline Brandon Haynes, MD Resident Physician Department of Urology Jelena Svircev, MD Assistant Professor Department of Rehabilitation Medicine Anatomy and Bladder Physiology Bladder
More informationTransurethral Resection of Prostate (TURP)
Transurethral Resection of Prostate (TURP) Department of Urology Patient Information What What and and where where is the is prostate? the prostate? The prostate is a small gland, about the size of a walnut,
More informationURGE MOTOR INCONTINENCE
URGE MOTOR INCONTINENCE URGE INCONTINENCE COMMONEST TYPE IN ELDERLY WOMEN Causes: 1 - Defects in CNS regulation Stroke Parkinson s disease Dementia (Alzheimer s and other types) Normopressure hydrocephalus
More informationManaging Erectile Dysfunction
Managing Erectile Dysfunction Lewis E. Harpster MD, FACS Urology of Central PA 4/23/16 1 Objectives 1. Review physiologic mechanism of erection 2. Discuss medical management of ED 3. Discuss surgical management
More informationUrinary Incontinence. Lee A. Jennings, MD, MSHS. Assistant Professor Reynolds Department of Geriatrics University of Oklahoma Health Sciences Center
Urinary Incontinence Lee A. Jennings, MD, MSHS Assistant Professor Reynolds Department of Geriatrics University of Oklahoma Health Sciences Center Slides adapted from Alison Moore, MD, MPH University of
More informationErectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid
Erectile dysfunction By Anas Hindawi Supervised by Dr Khalid AL Sayyid ED is the persistent/recurrent inability to attain and/or maintain a penile erection rigid enough for satisfactory sexual intercourse
More informationBenign Prostatic Hyperplasia Case Study 2. Medical Student Case-Based Learning
Benign Prostatic Hyperplasia Case Study 2 Medical Student Case-Based Learning The Case of Mr. Presley s Urinary Retention Mr. Presley presents to the emergency department in urinary retention. You are
More informationJan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT
Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning
More informationOveractive Bladder Syndrome
Overactive Bladder Syndrome behavioural modifications to pharmacological and surgical treatments Dr Jos Jayarajan Urologist Austin Health, Eastern Health Warringal Private, Northpark Private, Epworth Overactive
More information13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U
ERECTILE DYSFUNCTION Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U 1 2 3 So what is impotence or erectile dysfunction..? The persistent inability to achieve or maintain
More informationJan Farrell. Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT
Jan Farrell Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT Aims of session To promote discussion / interaction Opportunity to discuss with peers Promote learning / share
More informationExperience the Innovative Therapy for Benign Prostate Enlargement
Experience the Innovative Therapy for Benign Prostate Enlargement A Guide to Treatment of Benign Prostatic Hyperplasia 1. 2. The Prostate The prostate gland is a part of the male reproductive system. A
More informationCooled ThermoTherapy TM
Are BPH Medications Weighing You Down? Think Outside the Pillbox Cooled ThermoTherapy TM A non-surgical, 30 minute in-office treatment that provides long-term relief from BPH symptoms and urinary obstruction
More informationMALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
MALE SEXUAL DYSFUNCTION Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara DEFINITION The inability to achieve a satisfactory sexual relationship May involve : - inadequacy
More informationChapter 18: Glossary
Chapter 18: Glossary Sutter Health Cancer Service Line: Prostate Committee Advanced cancer: When the cancer has spread to other parts of the body (including lymph nodes, bones, or other organs) and is
More informationManagement of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005
Management of Voiding Problems in Older Men Dr. John Fenn Consultant, QEH 10 th October, 2005 Voiding Problems Poor stream Hesitancy Straining Incomplete emptying Intermittent micturition Terminal dribbling
More informationTHE JOHNS HOPKINS WHITE PAPERS. prostate Disorders
THE JOHNS HOPKINS WHITE PAPERS prostate Disorders 2 0 1 0 H. Ballentine Carter, M.D. JOHNS HOPKINS MEDICINE BALTIMORE, MARYLAND Dear Reader: Welcome to the 2010 Prostate Disorders White Paper your personal
More informationLoss of Bladder Control
BLADDER HEALTH Loss of Bladder Control SURGERY TO TREAT URINARY INCONTINENCE AUA FOUNDATION OFFICIAL FOUNDATION OF THE AMERICAN UROLOGICAL ASSOCIATION What Is Urinary Incontinence? Urinary incontinence
More informationUW MEDICINE PATIENT EDUCATION. About Your Surgery DRAFT
UW MEDICINE PATIENT EDUCATION About Your Surgery Transurethral resection of the prostate (TURP) This handout describes a transurethral resection of the prostate. It also gives instructions to follow before
More informationUrinary incontinence in women & men
Urinary incontinence in women & men Dr. Blayne Welk Assistant Professor, Western University, London, ON, Canada Part 1: INCONTINENCE IN WOMEN Urinary incontinence is common. About 1 in 4 young women, and
More information